While Xebra Brands (CSE: XBRA)(OTCQB: XBRAF) waits on further cannabis developments in Mexico, the company commenced formal cannabis cultivation in the Netherlands, including THC varietals.
In fact, according to the company, “As 1 of only 5 companies to be selected by the Dutch government to participate in trial medicinal cannabis cultivation, Xebra is endeavoring to be awarded 1 of 2 licenses, with a contract for up to 6 years, providing for revenues of up to US$79 million (€70.5 million), to co-supply all pharma-grade cannabis to be sold in the Netherlands.”
Further progress in both Mexico and the Netherlands could be a substantial catalyst for Xebra Brand. It could also strongly impact Aurora Cannabis (NASDAQ:ACB)(TSX:ACB), Canopy Growth (TSX:WEED)(NASDAQ:CGC), Tilray Inc. (NASDAQ:TLRY)(TSX:TLRY), and OrganiGram Holdings (NASDAQ:OGI)(TSX:OGI).